Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2000Journal of Clinical PathologyOpen Access

Recommendations for HER2 testing in the UK

View Full Paper
Ask AI
Bookmark
Share

Authors

Ian O. Ellis
Ian O. EllisUniversity of Chichester
Mitch Dowsett
Mitch DowsettBrighton and Sussex Medical SchoolJBJohn M.S. BartlettBrighton and Sussex Medical School

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ellis et al. (2000) studied this question.

synapsesocial.com/papers/6a72eb120659c579cd60d770https://doi.org/10.1136/jcp.53.12.890
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays2000 · 182 citations
  2. 2Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System1999 · 457 citations
  3. 3HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.1997 · 810 citations
  4. 4The significance of histological determination of HER-2 status in breast cancer2000 · 12 citations
  5. 5Humanization of an anti-p185HER2 antibody for human cancer therapy.1992 · 1,941 citations